Rice, Todd W <br/><br/>
Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis.  [electronic resource] 

 -  Critical care medicine  Sep 2006 
 - 2271-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Comment 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Standard No.: </label>10.1097/01.CCM.0000230385.82679.34  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--blood<br/>Bronchoalveolar Lavage Fluid--chemistry<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Immunologic Factors--therapeutic use<br/>Infusions, Intravenous<br/>Intensive Care Units--statistics & numerical data<br/>Interleukin-6--analysis<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Respiration, Artificial--statistics & numerical data<br/>Sepsis--drug therapy<br/>Sheep--immunology<br/>Tumor Necrosis Factor-alpha--analysis